References
- Position Statement: Role of progestogen in hormone therapy for postmenopausal women: position statement of the North American Menopause Society. Menopause 2003;10:113–32
- Position Statement: The 2012 hormone therapy position statement of the North American Menopause Society. Menopause 2012;19:257–71
- Stanczyk FZ, Paulson RJ, Roy S. Percutaneous administration of progesterone: blood levels and endometrial protection. Menopause 2005;12:232–7
- Burry KA, Patton PE, Hermsmeyer K. Percutaneous absorption of progesterone in postmenopausal women treated with transdermal estrogen. Am J Obstet Gynecol 1999;180:1504–11
- Carey BJ, Carey AH, Patel S, Carter G, Studd JW. A study to evaluate serum and urinary hormone levels following short and long term administration of two regimens of progesterone cream in postmenopausal women. BJOG 2000;107:722–6
- Cooper A, Spencer C, Whitehead MI, Ross D, Bernard GJ, Collins WP. Systemic absorption of progesterone from Progest cream in postmenopausal women. Lancet 1998;31:1255–6
- Wren BG, McFarland K, Edwards L, et al. Effect of sequential transdermal progesterone cream on endometrium, bleeding pattern, and plasma progesterone and salivary progesterone levels in postmenopausal women. Climacteric 2000;3:155–60
- Lewis JG, McGill H, Patton VM, Elder PA. Caution on the use of saliva measurements to monitor absorption of progesterone from transdermal creams in postmenopausal women. Maturitas 2002;41:1–6
- Leonetti HB, Wilson KJ, Anasti JN. Topical progesterone cream has an anti proliferative effect on estrogen-stimulated endometrium. Fertil Steril 2003;79:221–2
- Landes J, Leonetti HB. Topical progesterone cream: An alternative progestin in hormone replacement therapy. Obstet Gynecol 2003;101(Suppl 1):56
- Du JY, Sanchez P, Kim L, Azen CG, Zava DT, Stanczyk FZ. Percutaneous progesterone delivery via cream or gel application in postmenopausal women: a randomized cross-over study of progesterone levels in serum, whole blood, saliva, and capillary blood. Menopause 2013;20:1169–75
- O’Leary P, Feddema P, Chan K, Taranto M, Smith M, Evans S. Salivary, but not serum or urinary, levels of progesterone are elevated after topical application of progesterone cream to pre- and postmenopausal women. Clin Endocrinol (Oxf) 2000;53:615–20
- Bello SM, Mezrow G, Shoupe D, Winer SA, Stanczyk FZ. Administration of progesterone by use of a percutaneous gel in postmenopausal women. Presented at the 45th Annual Meeting of the Pacific Coast Fertility Society, Indian Wells, CA, USA, April 10–13, 1997
- Bhavnani BR, Stanczyk FZ. Misconception and concerns about bioidentical hormones used for custom-compounded hormone therapy. JCEM 2012;97:756–9